Global Pharmaceutical Survey 2012-2013: Market Trends, Buyer Spend and Procurement Strategies

Overall, throughout the global pharmaceutical industry, 47% of respondents are "more optimistic" about revenue growth for their company over the next 12 months as compared with the previous 12 months. With the recovery of national economies in early 2010, revenue growth expectations increased in 2010 and rose further in 2011.

However with the economic slowdown in the later part of 2011 in Europe and North America, companies were forced to rethink about their growth prospects for 2012. The top three key expected changes in business structure for 2012 include the addition of "new products and service" portfolios, "improvement of operational efficiency", and "expansion in current markets". Moreover, "new product development" and "new facility acquisition" will record significant increase in capital expenditure over the next 12 months.

This report from ICD Research provides the reader with a definitive analysis of industry outlook and explores how opportunities and demand are set to change in 2012-2013.